Mounjaro 10 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB26FPLKP
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,204
Award facts
- Contract value 100% obligated
- $6,204.38 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $6,204.38 delivery order to AmerisourceBergen Drug Corp for Mounjaro (tirzepatide) 10 mg/0.5 mL pen injectors on October 30, 2025, with completion targeted for October 31, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement through this prime indefinite delivery vehicle and associated delivery orders. The SPE2DX contract enables the company to supply a broad range of pharmaceutical products and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide. Mounjaro is a diabetes medication representing the type of specialized pharmaceutical commodities that fall within the company's extensive federal contract portfolio, which spans multiple therapeutic domains including neurological treatments, pain management medications, and vaccines.
Quick answers
Who was awarded contract SPE2DB26FPLKP?
SPE2DB26FPLKP was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 30, 2025.
How much is contract SPE2DB26FPLKP worth?
The government has obligated $6,204 on SPE2DB26FPLKP.
Is contract SPE2DB26FPLKP an order under another contract?
Yes. SPE2DB26FPLKP is a delivery order under SPE2DB20D2001, an indefinite delivery contract.
Was contract SPE2DB26FPLKP competed?
The extent of competition for SPE2DB26FPLKP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award